Next-Generation Toxicology in Pharma & Biotech NEXTGENTOX on October 21-22, 2026 in Basel, Switzerland

NEXT-GENERATION TOXICOLOGY IN PHARMA & BIOTECH

Date: 21–22 October 2026

Time: Registration/Login from 08:45 | Sessions begin at 09:00

Venue: Basel, Switzerland & Online Live Stream

Expert Trainers:

• Dr. Pelin Candarlioglu – Founder & Director, 3D and 3Rs Ltd

• Richard Knight, PhD, ERT – Co-founder, ApconiX

This advanced training course is designed for professionals in Pharmaceuticals, Biotechnology, Drug Safety, Toxicology, Preclinical Development, Pharmacology, and Regulatory Affairs. Participants will gain practical knowledge of Regulatory Toxicology, Investigative Toxicology, New Approach Methodologies (NAMs), Microphysiological Systems (MPS), Integrated Testing Strategies (IATA), Risk Assessment, Data Quality, Reproducibility, and AI-Enabled Toxicology.

**What Attendees Will Learn:**

✔ Modern toxicology approaches for drug development

✔ Regulatory expectations and safety assessment strategies

✔ Human-relevant models and innovative testing methods

✔ Risk evaluation and evidence-based decision-making

✔ Applications of AI in toxicology and drug safety

✔ Real-world case studies and interactive workshops

**Key Benefits:**

✔ Learn directly from internationally recognized experts

✔ Participate in hands-on exercises and group discussions

✔ Gain practical insights applicable to pharmaceutical and biotech projects

✔ Network with industry professionals and peers

✔ Receive comprehensive course materials and a **Certificate of Completion**

This course provides a unique opportunity to explore the future of **Drug Safety, Toxicology, and Pharmaceutical Innovation** while developing practical skills that can be immediately applied within research and development programs.